Poo JL - Search Results

1

[Treatment of patients with recurrence or who do not respond to the first treatment against hepatitis C].

Poo JL. Poo JL. Rev Gastroenterol Mex. 2002 Oct;67 Suppl 2:S45-8. Rev Gastroenterol Mex. 2002. PMID: 12712853 Review. Spanish.

2

Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study.

Poo JL, Sánchez-Avila F, Kershenobich D, García-Samper X, Gongora J, Uribe M. Poo JL, et al. J Gastroenterol Hepatol. 2004 Dec;19 Suppl 6:S79-81. doi: 10.1111/j.1440-1746.2004.03634.x. J Gastroenterol Hepatol. 2004. PMID: 15546256 Clinical Trial.

3

Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study.

Poo JL, Sánchez-Avila F, Kershenobich D, García-Samper X, Gongora J, Uribe M. Poo JL, et al. J Gastroenterol Hepatol. 2004 Dec;19(12):S79-81. J Gastroenterol Hepatol. 2004. PMID: 15641210

4

Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders.

Poo JL, Sánchez Avila F, Kershenobich D, García Samper X, Torress-Ibarra R, Góngora J, Cano C, Parada M, Uribe M. Poo JL, et al. Ann Hepatol. 2008 Oct-Dec;7(4):369-75. Ann Hepatol. 2008. PMID: 19034238 Free article. Clinical Trial.

5

Hepatitis C virus infection and non-Hodgkin's lymphoma: a review and case report of nine patient.

Lizardi-Cervera J, Poo JL, Romero-Mora K, Castañeda B, Pichardo-Bahena R, Morán S, Uribe M. Lizardi-Cervera J, et al. Among authors: poo jl. Ann Hepatol. 2006 Oct-Dec;5(4):257-62. Ann Hepatol. 2006. PMID: 17151577 Free article. Review.

6

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

Silva M, Poo J, Wagner F, Jackson M, Cutler D, Grace M, Bordens R, Cullen C, Harvey J, Laughlin M. Silva M, et al. J Hepatol. 2006 Aug;45(2):204-13. doi: 10.1016/j.jhep.2006.03.008. Epub 2006 Apr 18. J Hepatol. 2006. PMID: 16780997 Clinical Trial.

7

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

Poo JL, Góngora J, Sánchez-Avila F, Aguilar-Castillo S, García-Ramos G, Fernández-Zertuche M, Rodríguez-Fragoso L, Uribe M. Poo JL, et al. Ann Hepatol. 2006 Oct-Dec;5(4):281-8. Ann Hepatol. 2006. PMID: 17151582 Free article. Clinical Trial.

8

Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.

Bruix J, Poynard T, Colombo M, Schiff E, Burak K, Heathcote EJ, Berg T, Poo JL, Mello CB, Guenther R, Niederau C, Terg R, Bedossa P, Boparai N, Griffel LH, Burroughs M, Brass CA, Albrecht JK; EPIC3 Study Group. Bruix J, et al. Among authors: poo jl. Gastroenterology. 2011 Jun;140(7):1990-9. doi: 10.1053/j.gastro.2011.03.010. Epub 2011 Mar 17. Gastroenterology. 2011. PMID: 21419770 Clinical Trial.

9

Etiology of liver cirrhosis in Mexico.

Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juórez A, Castñeda B, Sánchez-Avila F, Poo JL, Guevara González L, Lizardi J, Valdovinos MA, Uribe M, Contreras AM, Tirado P, Aguirre J, Rivera-Benítez C, Santiago-Santiago R, Bosques-Padilla F, Muñoz L, Guerroro A, Ramos M, Rodríguez-Hernández H, Jacobo-Karam J; Grupo de Estudio, Asociación Mexicana de Hepatología. Méndez-Sánchez N, et al. Among authors: poo jl. Ann Hepatol. 2004 Jan-Mar;3(1):30-3. Ann Hepatol. 2004. PMID: 15118577 Free article.

10

Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.

Uribe M, Morán S, Poo JL, Méndez-Sánchez N, Guevara L, García-Ramos G. Uribe M, et al. Among authors: poo jl. Scand J Gastroenterol. 1998 Oct;33(10):1099-106. doi: 10.1080/003655298750026822. Scand J Gastroenterol. 1998. PMID: 9829367 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters